Literatur
Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I: Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989;81:116–124.
Gottesman MM, Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385–427.
Scheper RJ, Broxterman HJ, Scheffer GL, Meijer CJLM, Pinedo HM: Drug-transporter proteins in clinical multidrug resistance. Clin Chim Acta 1992;206:25–32.
Arceci RJ: Clinical significance of p-glycoprotein in multidrug resistance malignancies. Blood 1993;81:2215–2222.
Dalton WS: Drug resistance modulation in the laboratory and the clinic. Sem Oncol 1993;20:64–69.
Elbling L, Berger W, Rehberger A, Waldhör T, Micksche M: P-glycoprotein regulates chemosensitivity in early developmental stages in the mouse. FASEB J 1993;7:1499–1506.
Berger W, Elbling L, Minai-Pour M, Vetterlein M, Pirker R, Kokoschka EM, Micksche M: Intrinsic MDR-1 gene and p-glycoprotein expression in human melanoma cell lines. Int J Cancer 1994;59 (im Druck).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berger, W., Micksche, M. Eingeladener Kommentar: Multidrug-Resistenz P-Glycoprotein: klinische Relevanz. Acta Chir Austriaca 26, 426–428 (1994). https://doi.org/10.1007/BF02620055
Issue Date:
DOI: https://doi.org/10.1007/BF02620055